

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | photoreceptor cell maintenance (GO:0045494) | 9.14149018 |
| 2 | midgut development (GO:0007494) | 9.08193244 |
| 3 | detection of light stimulus involved in visual perception (GO:0050908) | 8.73533002 |
| 4 | detection of light stimulus involved in sensory perception (GO:0050962) | 8.73533002 |
| 5 | photoreceptor cell development (GO:0042461) | 8.66788708 |
| 6 | eye photoreceptor cell development (GO:0042462) | 8.35484529 |
| 7 | protein-chromophore linkage (GO:0018298) | 8.35379804 |
| 8 | urea cycle (GO:0000050) | 8.15474112 |
| 9 | homocysteine metabolic process (GO:0050667) | 8.11874302 |
| 10 | phototransduction (GO:0007602) | 8.02717320 |
| 11 | phototransduction, visible light (GO:0007603) | 8.00971224 |
| 12 | detection of visible light (GO:0009584) | 7.71484232 |
| 13 | detection of light stimulus (GO:0009583) | 7.60343721 |
| 14 | positive regulation of guanylate cyclase activity (GO:0031284) | 7.59910664 |
| 15 | urea metabolic process (GO:0019627) | 7.43015239 |
| 16 | regulation of guanylate cyclase activity (GO:0031282) | 6.87872518 |
| 17 | nitrogen cycle metabolic process (GO:0071941) | 6.63305186 |
| 18 | retinal rod cell development (GO:0046548) | 6.59615977 |
| 19 | negative regulation of complement activation (GO:0045916) | 6.56698281 |
| 20 | visual perception (GO:0007601) | 6.49907394 |
| 21 | positive regulation of vascular permeability (GO:0043117) | 6.45987511 |
| 22 | sensory perception of light stimulus (GO:0050953) | 6.42144827 |
| 23 | nuclear pore complex assembly (GO:0051292) | 6.34855999 |
| 24 | folic acid metabolic process (GO:0046655) | 6.22043600 |
| 25 | citrulline metabolic process (GO:0000052) | 6.19363921 |
| 26 | cGMP-mediated signaling (GO:0019934) | 6.15950151 |
| 27 | GMP metabolic process (GO:0046037) | 6.14722128 |
| 28 | negative regulation of protein activation cascade (GO:2000258) | 5.90602441 |
| 29 | citrulline biosynthetic process (GO:0019240) | 5.76984384 |
| 30 | detection of external stimulus (GO:0009581) | 5.40886292 |
| 31 | cellular response to light stimulus (GO:0071482) | 5.40708017 |
| 32 | nuclear pore organization (GO:0006999) | 5.30333554 |
| 33 | detection of abiotic stimulus (GO:0009582) | 5.28846601 |
| 34 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.26349833 |
| 35 | diaphragm development (GO:0060539) | 5.13304270 |
| 36 | cAMP catabolic process (GO:0006198) | 5.09567808 |
| 37 | regulation of clathrin-mediated endocytosis (GO:2000369) | 5.08539448 |
| 38 | photoreceptor cell differentiation (GO:0046530) | 5.04219998 |
| 39 | eye photoreceptor cell differentiation (GO:0001754) | 5.04219998 |
| 40 | response to growth hormone (GO:0060416) | 4.90329325 |
| 41 | negative regulation of humoral immune response (GO:0002921) | 4.88522374 |
| 42 | regulation of cGMP metabolic process (GO:0030823) | 4.80832608 |
| 43 | response to dexamethasone (GO:0071548) | 4.69063776 |
| 44 | pore complex assembly (GO:0046931) | 4.65451153 |
| 45 | protein localization to synapse (GO:0035418) | 4.65228523 |
| 46 | retina development in camera-type eye (GO:0060041) | 4.57313127 |
| 47 | positive regulation of vesicle fusion (GO:0031340) | 4.48839526 |
| 48 | hepatocyte differentiation (GO:0070365) | 4.48462808 |
| 49 | positive regulation of cGMP biosynthetic process (GO:0030828) | 4.48125485 |
| 50 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.47760320 |
| 51 | cyclic nucleotide catabolic process (GO:0009214) | 4.42020035 |
| 52 | skeletal muscle organ development (GO:0060538) | 4.41539384 |
| 53 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.40716674 |
| 54 | negative regulation of vascular permeability (GO:0043116) | 4.39474378 |
| 55 | polyketide metabolic process (GO:0030638) | 4.32445936 |
| 56 | doxorubicin metabolic process (GO:0044598) | 4.32445936 |
| 57 | daunorubicin metabolic process (GO:0044597) | 4.32445936 |
| 58 | response to histamine (GO:0034776) | 4.28975390 |
| 59 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.26043528 |
| 60 | cellular response to fatty acid (GO:0071398) | 4.24269737 |
| 61 | regulation of cGMP biosynthetic process (GO:0030826) | 4.21423573 |
| 62 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.11793001 |
| 63 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.08883629 |
| 64 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.08558742 |
| 65 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.99484386 |
| 66 | positive regulation of cGMP metabolic process (GO:0030825) | 3.95972254 |
| 67 | positive regulation of neurotransmitter transport (GO:0051590) | 3.90558286 |
| 68 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.90551666 |
| 69 | folic acid transport (GO:0015884) | 3.83100570 |
| 70 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.80599387 |
| 71 | adaptation of signaling pathway (GO:0023058) | 3.76276454 |
| 72 | mitotic chromosome condensation (GO:0007076) | 3.74443661 |
| 73 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 3.73152202 |
| 74 | establishment of apical/basal cell polarity (GO:0035089) | 3.68605170 |
| 75 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.68215304 |
| 76 | glomerular visceral epithelial cell development (GO:0072015) | 3.66989640 |
| 77 | response to food (GO:0032094) | 3.58671963 |
| 78 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.54956302 |
| 79 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.52927544 |
| 80 | triglyceride catabolic process (GO:0019433) | 3.48441896 |
| 81 | cysteine metabolic process (GO:0006534) | 3.45631710 |
| 82 | cellular response to radiation (GO:0071478) | 3.44946362 |
| 83 | synaptic vesicle maturation (GO:0016188) | 3.40516819 |
| 84 | nonmotile primary cilium assembly (GO:0035058) | 3.34941332 |
| 85 | response to nitrosative stress (GO:0051409) | 3.34598248 |
| 86 | regulation of translational fidelity (GO:0006450) | 3.34476223 |
| 87 | glutamine metabolic process (GO:0006541) | 3.33758959 |
| 88 | notochord development (GO:0030903) | 3.32319741 |
| 89 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.29738017 |
| 90 | startle response (GO:0001964) | 3.29729697 |
| 91 | estrogen biosynthetic process (GO:0006703) | 3.27771322 |
| 92 | sensory perception (GO:0007600) | 3.27297603 |
| 93 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.25014801 |
| 94 | cellular protein complex localization (GO:0034629) | 3.23170519 |
| 95 | regulation of vesicle fusion (GO:0031338) | 3.22908876 |
| 96 | membrane hyperpolarization (GO:0060081) | 3.21830871 |
| 97 | DNA unwinding involved in DNA replication (GO:0006268) | 3.18411148 |
| 98 | regulation of mitotic spindle organization (GO:0060236) | 3.18084426 |
| 99 | regulation of synaptic vesicle transport (GO:1902803) | 3.16118795 |
| 100 | COPI coating of Golgi vesicle (GO:0048205) | 3.15118602 |
| 101 | Golgi transport vesicle coating (GO:0048200) | 3.15118602 |
| 102 | mitotic sister chromatid segregation (GO:0000070) | 3.15045868 |
| 103 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.14544045 |
| 104 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.13100834 |
| 105 | tricarboxylic acid metabolic process (GO:0072350) | 3.11549500 |
| 106 | glomerular epithelial cell development (GO:0072310) | 3.09983925 |
| 107 | ribosome assembly (GO:0042255) | 3.09781366 |
| 108 | neutral lipid catabolic process (GO:0046461) | 3.08351995 |
| 109 | acylglycerol catabolic process (GO:0046464) | 3.08351995 |
| 110 | NADH metabolic process (GO:0006734) | 3.08058708 |
| 111 | short-term memory (GO:0007614) | 3.06983527 |
| 112 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.04529386 |
| 113 | glycogen catabolic process (GO:0005980) | 3.01978249 |
| 114 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.01956708 |
| 115 | glucan catabolic process (GO:0009251) | 3.01416135 |
| 116 | presynaptic membrane assembly (GO:0097105) | 3.00023137 |
| 117 | chemosensory behavior (GO:0007635) | 2.99749301 |
| 118 | negative regulation of gluconeogenesis (GO:0045721) | 2.99645390 |
| 119 | phospholipid translocation (GO:0045332) | 2.98620837 |
| 120 | lipid translocation (GO:0034204) | 2.98620837 |
| 121 | positive regulation of membrane potential (GO:0045838) | 2.97973392 |
| 122 | neuron cell-cell adhesion (GO:0007158) | 2.97511547 |
| 123 | response to light stimulus (GO:0009416) | 2.94819440 |
| 124 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.91362915 |
| 125 | DNA strand elongation (GO:0022616) | 2.90583693 |
| 126 | sister chromatid segregation (GO:0000819) | 2.89229146 |
| 127 | mitotic nuclear envelope disassembly (GO:0007077) | 2.89185853 |
| 128 | retina layer formation (GO:0010842) | 2.89154289 |
| 129 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.89066646 |
| 130 | establishment of monopolar cell polarity (GO:0061162) | 2.87856767 |
| 131 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.87856767 |
| 132 | regulation of axon guidance (GO:1902667) | 2.87138851 |
| 133 | negative regulation of hormone metabolic process (GO:0032351) | 2.84827916 |
| 134 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.84178113 |
| 135 | folic acid-containing compound metabolic process (GO:0006760) | 2.83748867 |
| 136 | biotin metabolic process (GO:0006768) | 2.83149955 |
| 137 | axonal fasciculation (GO:0007413) | 2.82960094 |
| 138 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.81693571 |
| 139 | regulation of postsynaptic membrane potential (GO:0060078) | 2.80403420 |
| 140 | DNA replication initiation (GO:0006270) | 2.80105264 |
| 141 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.80007948 |
| 142 | early endosome to late endosome transport (GO:0045022) | 2.79854770 |
| 143 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.79685545 |
| 144 | glutamate secretion (GO:0014047) | 2.78825747 |
| 145 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.78801606 |
| 146 | cellular polysaccharide catabolic process (GO:0044247) | 2.78536380 |
| 147 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.78244485 |
| 148 | tricarboxylic acid cycle (GO:0006099) | 2.78233560 |
| 149 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.78211196 |
| 150 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.77993523 |
| 151 | glycoside metabolic process (GO:0016137) | 2.76809752 |
| 152 | tRNA methylation (GO:0030488) | 2.76317662 |
| 153 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.76106106 |
| 154 | regulation of centriole replication (GO:0046599) | 2.74273307 |
| 155 | nuclear envelope disassembly (GO:0051081) | 2.73380557 |
| 156 | membrane disassembly (GO:0030397) | 2.73380557 |
| 157 | neuron development (GO:0048666) | 2.72713342 |
| 158 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.72380208 |
| 159 | synaptic transmission, glutamatergic (GO:0035249) | 2.71584441 |
| 160 | primary alcohol catabolic process (GO:0034310) | 2.70727528 |
| 161 | regulation of neurotransmitter secretion (GO:0046928) | 2.70073716 |
| 162 | behavioral response to ethanol (GO:0048149) | 2.69418398 |
| 163 | synaptic vesicle endocytosis (GO:0048488) | 2.69342809 |
| 164 | iron ion import (GO:0097286) | 2.68678120 |
| 165 | cellular potassium ion homeostasis (GO:0030007) | 2.68572292 |
| 166 | response to laminar fluid shear stress (GO:0034616) | 2.68165129 |
| 167 | synaptic vesicle exocytosis (GO:0016079) | 2.65999019 |
| 168 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.64892181 |
| 169 | regulation of chromatin binding (GO:0035561) | 2.64691796 |
| 170 | postsynaptic membrane organization (GO:0001941) | 2.64198896 |
| 171 | locomotory exploration behavior (GO:0035641) | 2.63888590 |
| 172 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.63833826 |
| 173 | UV protection (GO:0009650) | 2.63717990 |
| 174 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.63552926 |
| 175 | protein complex localization (GO:0031503) | 2.63477247 |
| 176 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.63150751 |
| 177 | carnitine shuttle (GO:0006853) | 2.62556694 |
| 178 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.62222892 |
| 179 | glomerular basement membrane development (GO:0032836) | 2.60724523 |
| 180 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.59746928 |
| 181 | fatty acid homeostasis (GO:0055089) | 2.59132408 |
| 182 | ribosome biogenesis (GO:0042254) | 2.57201284 |
| 183 | neuron-neuron synaptic transmission (GO:0007270) | 2.57022610 |
| 184 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.56579278 |
| 185 | regulation of vascular permeability (GO:0043114) | 2.55941617 |
| 186 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.54807671 |
| 187 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.51466029 |
| 188 | regulation of spindle organization (GO:0090224) | 2.51129012 |
| 189 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.50684952 |
| 190 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.50379598 |
| 191 | regulation of centrosome cycle (GO:0046605) | 2.49948898 |
| 192 | protein localization to chromosome, centromeric region (GO:0071459) | 2.49752845 |
| 193 | regulation of complement activation (GO:0030449) | 2.48184016 |
| 194 | carnitine transmembrane transport (GO:1902603) | 2.47754223 |
| 195 | polarized epithelial cell differentiation (GO:0030859) | 2.47629221 |
| 196 | polysaccharide catabolic process (GO:0000272) | 2.46002018 |
| 197 | sulfur amino acid metabolic process (GO:0000096) | 2.44995128 |
| 198 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 13.7023681 |
| 199 | rhodopsin mediated signaling pathway (GO:0016056) | 13.4063395 |
| 200 | retinal cone cell development (GO:0046549) | 11.6196035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.44595228 |
| 2 | ZNF263_19887448_ChIP-Seq_K562_Human | 6.77156334 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.69383640 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.33238647 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.89422393 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.24661472 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 3.19139606 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.04693886 |
| 9 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.91939209 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.84935930 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.58518368 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.43289894 |
| 13 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.40323074 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.36853182 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.36370381 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.32917130 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.24443401 |
| 18 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.17572818 |
| 19 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.14761901 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.14410496 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.12144071 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.10388315 |
| 23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.08339633 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.02367351 |
| 25 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.02029700 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.01798203 |
| 27 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.01782688 |
| 28 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.01344859 |
| 29 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.99760155 |
| 30 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.98349807 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.97534195 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.96949980 |
| 33 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.95027128 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.94571970 |
| 35 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.93760723 |
| 36 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92957811 |
| 37 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.91653273 |
| 38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.87990610 |
| 39 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.86253640 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.83286413 |
| 41 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.81318278 |
| 42 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.81290061 |
| 43 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.78463942 |
| 44 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.78463942 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.76788584 |
| 46 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.75858261 |
| 47 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.74741299 |
| 48 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74156268 |
| 49 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.72282084 |
| 50 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.71862837 |
| 51 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.69466265 |
| 52 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.65936585 |
| 53 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65626225 |
| 54 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.65570644 |
| 55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.62410801 |
| 56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.60788993 |
| 57 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.58069099 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.57765512 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.57407955 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57101706 |
| 61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.57018099 |
| 62 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.56623741 |
| 63 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.56591213 |
| 64 | TP53_16413492_ChIP-PET_HCT116_Human | 1.56429185 |
| 65 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.55028872 |
| 66 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.54656533 |
| 67 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.54310243 |
| 68 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.52623789 |
| 69 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.52408198 |
| 70 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.52050859 |
| 71 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.51793375 |
| 72 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.51392886 |
| 73 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.51217391 |
| 74 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50490521 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.48001573 |
| 76 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.47766730 |
| 77 | FUS_26573619_Chip-Seq_HEK293_Human | 1.47673714 |
| 78 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.46351280 |
| 79 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.45448643 |
| 80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.45275593 |
| 81 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.45089915 |
| 82 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.45064660 |
| 83 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.44965655 |
| 84 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.44720410 |
| 85 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.44720410 |
| 86 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.44570857 |
| 87 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.42509623 |
| 88 | STAT3_23295773_ChIP-Seq_U87_Human | 1.41798011 |
| 89 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.41668738 |
| 90 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.40695640 |
| 91 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40341993 |
| 92 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39696540 |
| 93 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39225419 |
| 94 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.38754732 |
| 95 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.38381523 |
| 96 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.38362320 |
| 97 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.38071667 |
| 98 | AR_19668381_ChIP-Seq_PC3_Human | 1.37676617 |
| 99 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.37465174 |
| 100 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.35682747 |
| 101 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.34974978 |
| 102 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34947768 |
| 103 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33942247 |
| 104 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.33462143 |
| 105 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.30197228 |
| 106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29435895 |
| 107 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29257437 |
| 108 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.28986108 |
| 109 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28715898 |
| 110 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28040683 |
| 111 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.27283588 |
| 112 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.27067352 |
| 113 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.25873813 |
| 114 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.25863033 |
| 115 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.25297863 |
| 116 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24683084 |
| 117 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23560347 |
| 118 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.23224372 |
| 119 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.23024319 |
| 120 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22367588 |
| 121 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22140535 |
| 122 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.21843549 |
| 123 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.21407300 |
| 124 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21209280 |
| 125 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.20372470 |
| 126 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.18924138 |
| 127 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18669385 |
| 128 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.18586258 |
| 129 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.18577565 |
| 130 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16899489 |
| 131 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16354544 |
| 132 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15111059 |
| 133 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14513339 |
| 134 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13405503 |
| 135 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.13383069 |
| 136 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12818515 |
| 137 | AR_25329375_ChIP-Seq_VCAP_Human | 1.10844334 |
| 138 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10598568 |
| 139 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09870734 |
| 140 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09383354 |
| 141 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09370548 |
| 142 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.09310003 |
| 143 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09214655 |
| 144 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09158542 |
| 145 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.08016001 |
| 146 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07407330 |
| 147 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07394628 |
| 148 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06900598 |
| 149 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05135704 |
| 150 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.04680837 |
| 151 | TBL1_22424771_ChIP-Seq_293T_Human | 1.04236242 |
| 152 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04010504 |
| 153 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03636026 |
| 154 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02529115 |
| 155 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01583743 |
| 156 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01432813 |
| 157 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00824233 |
| 158 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.00808191 |
| 159 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00771183 |
| 160 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00613356 |
| 161 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99179274 |
| 162 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98843712 |
| 163 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.98660391 |
| 164 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98504952 |
| 165 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.98299705 |
| 166 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97525779 |
| 167 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96780746 |
| 168 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96723799 |
| 169 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96566881 |
| 170 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.95255537 |
| 171 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.95226900 |
| 172 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95080727 |
| 173 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94737460 |
| 174 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94547290 |
| 175 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94071856 |
| 176 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.93796175 |
| 177 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.93551207 |
| 178 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93044949 |
| 179 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92794951 |
| 180 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.92696334 |
| 181 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.92461195 |
| 182 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92369127 |
| 183 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91895107 |
| 184 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.91256791 |
| 185 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.91220289 |
| 186 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91117267 |
| 187 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.90857170 |
| 188 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89376836 |
| 189 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.88702367 |
| 190 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87817151 |
| 191 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87463653 |
| 192 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.87097789 |
| 193 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.86083722 |
| 194 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86067375 |
| 195 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.86054057 |
| 196 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85703241 |
| 197 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85703178 |
| 198 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.82158889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 9.11332252 |
| 2 | MP0005551_abnormal_eye_electrophysiolog | 8.48059635 |
| 3 | MP0005253_abnormal_eye_physiology | 5.89066607 |
| 4 | MP0006072_abnormal_retinal_apoptosis | 5.42940952 |
| 5 | MP0000013_abnormal_adipose_tissue | 4.31250585 |
| 6 | MP0002877_abnormal_melanocyte_morpholog | 3.93335569 |
| 7 | MP0003880_abnormal_central_pattern | 3.72028870 |
| 8 | MP0005623_abnormal_meninges_morphology | 3.54317685 |
| 9 | MP0003950_abnormal_plasma_membrane | 3.29144136 |
| 10 | MP0005195_abnormal_posterior_eye | 3.22714101 |
| 11 | MP0002090_abnormal_vision | 2.98554006 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.96173147 |
| 13 | MP0000003_abnormal_adipose_tissue | 2.95954663 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.89314987 |
| 15 | MP0005391_vision/eye_phenotype | 2.85870322 |
| 16 | MP0001324_abnormal_eye_pigmentation | 2.85759714 |
| 17 | MP0002009_preneoplasia | 2.74997393 |
| 18 | MP0010094_abnormal_chromosome_stability | 2.58464838 |
| 19 | MP0010352_gastrointestinal_tract_polyps | 2.55335048 |
| 20 | MP0000579_abnormal_nail_morphology | 2.54918105 |
| 21 | MP0004859_abnormal_synaptic_plasticity | 2.54325196 |
| 22 | MP0002229_neurodegeneration | 2.52080171 |
| 23 | MP0004957_abnormal_blastocyst_morpholog | 2.49739962 |
| 24 | MP0001661_extended_life_span | 2.45475003 |
| 25 | MP0008057_abnormal_DNA_replication | 2.31217492 |
| 26 | MP0001348_abnormal_lacrimal_gland | 2.25146842 |
| 27 | MP0003283_abnormal_digestive_organ | 2.20658817 |
| 28 | MP0006292_abnormal_olfactory_placode | 2.14874391 |
| 29 | MP0008058_abnormal_DNA_repair | 2.14604486 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 2.14316485 |
| 31 | MP0003693_abnormal_embryo_hatching | 2.11264492 |
| 32 | MP0003111_abnormal_nucleus_morphology | 2.10063772 |
| 33 | MP0010307_abnormal_tumor_latency | 1.98563363 |
| 34 | MP0005360_urolithiasis | 1.98143114 |
| 35 | MP0003077_abnormal_cell_cycle | 1.96129674 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.91279828 |
| 37 | MP0000490_abnormal_crypts_of | 1.90529885 |
| 38 | MP0005332_abnormal_amino_acid | 1.90199399 |
| 39 | MP0002752_abnormal_somatic_nervous | 1.90074794 |
| 40 | MP0003635_abnormal_synaptic_transmissio | 1.83272405 |
| 41 | MP0005076_abnormal_cell_differentiation | 1.82120217 |
| 42 | MP0005375_adipose_tissue_phenotype | 1.81530773 |
| 43 | MP0001968_abnormal_touch/_nociception | 1.80132660 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.79788726 |
| 45 | MP0003566_abnormal_cell_adhesion | 1.64381981 |
| 46 | MP0001764_abnormal_homeostasis | 1.61585319 |
| 47 | MP0006138_congestive_heart_failure | 1.61468504 |
| 48 | MP0004270_analgesia | 1.59966802 |
| 49 | MP0008932_abnormal_embryonic_tissue | 1.58137771 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.57582379 |
| 51 | MP0004885_abnormal_endolymph | 1.55121972 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.53692979 |
| 53 | MP0008438_abnormal_cutaneous_collagen | 1.50495864 |
| 54 | MP0002064_seizures | 1.46084059 |
| 55 | MP0010030_abnormal_orbit_morphology | 1.44599225 |
| 56 | MP0005501_abnormal_skin_physiology | 1.43212552 |
| 57 | MP0003786_premature_aging | 1.42859264 |
| 58 | MP0005085_abnormal_gallbladder_physiolo | 1.39856618 |
| 59 | MP0001486_abnormal_startle_reflex | 1.36897393 |
| 60 | MP0002063_abnormal_learning/memory/cond | 1.34233565 |
| 61 | MP0002272_abnormal_nervous_system | 1.30138409 |
| 62 | MP0005666_abnormal_adipose_tissue | 1.29811986 |
| 63 | MP0004019_abnormal_vitamin_homeostasis | 1.29140987 |
| 64 | MP0009745_abnormal_behavioral_response | 1.28535966 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.24132283 |
| 66 | MP0002572_abnormal_emotion/affect_behav | 1.23271270 |
| 67 | MP0003186_abnormal_redox_activity | 1.22460097 |
| 68 | MP0000733_abnormal_muscle_development | 1.22189309 |
| 69 | MP0002234_abnormal_pharynx_morphology | 1.18795529 |
| 70 | MP0003718_maternal_effect | 1.18047732 |
| 71 | MP0005670_abnormal_white_adipose | 1.16742267 |
| 72 | MP0008007_abnormal_cellular_replicative | 1.15259707 |
| 73 | MP0002971_abnormal_brown_adipose | 1.15126844 |
| 74 | MP0002697_abnormal_eye_size | 1.13123302 |
| 75 | MP0004233_abnormal_muscle_weight | 1.11963289 |
| 76 | MP0009697_abnormal_copulation | 1.08149768 |
| 77 | MP0003183_abnormal_peptide_metabolism | 1.06768932 |
| 78 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.06090067 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 1.05580916 |
| 80 | MP0003868_abnormal_feces_composition | 1.04738409 |
| 81 | MP0009643_abnormal_urine_homeostasis | 1.04625599 |
| 82 | MP0000350_abnormal_cell_proliferation | 1.04493013 |
| 83 | MP0003806_abnormal_nucleotide_metabolis | 1.03750746 |
| 84 | MP0004130_abnormal_muscle_cell | 1.01516535 |
| 85 | MP0000537_abnormal_urethra_morphology | 1.00430900 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 1.00142200 |
| 87 | MP0002139_abnormal_hepatobiliary_system | 0.98998450 |
| 88 | MP0009046_muscle_twitch | 0.98568047 |
| 89 | MP0005647_abnormal_sex_gland | 0.96817904 |
| 90 | MP0002067_abnormal_sensory_capabilities | 0.96106755 |
| 91 | MP0003984_embryonic_growth_retardation | 0.95942543 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.95583734 |
| 93 | MP0003252_abnormal_bile_duct | 0.95380535 |
| 94 | MP0002970_abnormal_white_adipose | 0.94394398 |
| 95 | MP0002060_abnormal_skin_morphology | 0.93872699 |
| 96 | MP0002166_altered_tumor_susceptibility | 0.93775437 |
| 97 | MP0002080_prenatal_lethality | 0.93184324 |
| 98 | MP0002088_abnormal_embryonic_growth/wei | 0.93029823 |
| 99 | MP0001672_abnormal_embryogenesis/_devel | 0.92213691 |
| 100 | MP0005380_embryogenesis_phenotype | 0.92213691 |
| 101 | MP0002822_catalepsy | 0.92142105 |
| 102 | MP0002269_muscular_atrophy | 0.91832301 |
| 103 | MP0008775_abnormal_heart_ventricle | 0.90907288 |
| 104 | MP0001501_abnormal_sleep_pattern | 0.90656876 |
| 105 | MP0009780_abnormal_chondrocyte_physiolo | 0.88881026 |
| 106 | MP0003045_fibrosis | 0.88736511 |
| 107 | MP0002736_abnormal_nociception_after | 0.87831057 |
| 108 | MP0005451_abnormal_body_composition | 0.87588019 |
| 109 | MP0002735_abnormal_chemical_nociception | 0.87010338 |
| 110 | MP0001730_embryonic_growth_arrest | 0.86277257 |
| 111 | MP0000462_abnormal_digestive_system | 0.86236437 |
| 112 | MP0004808_abnormal_hematopoietic_stem | 0.83862584 |
| 113 | MP0000762_abnormal_tongue_morphology | 0.83450609 |
| 114 | MP0004272_abnormal_basement_membrane | 0.82172041 |
| 115 | MP0002086_abnormal_extraembryonic_tissu | 0.81173691 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 0.80965242 |
| 117 | MP0002653_abnormal_ependyma_morphology | 0.80083224 |
| 118 | MP0004084_abnormal_cardiac_muscle | 0.79869648 |
| 119 | MP0004087_abnormal_muscle_fiber | 0.79090834 |
| 120 | MP0002896_abnormal_bone_mineralization | 0.78583294 |
| 121 | MP0004782_abnormal_surfactant_physiolog | 0.77539381 |
| 122 | MP0001984_abnormal_olfaction | 0.77146906 |
| 123 | MP0002733_abnormal_thermal_nociception | 0.76338575 |
| 124 | MP0001697_abnormal_embryo_size | 0.76217815 |
| 125 | MP0005083_abnormal_biliary_tract | 0.75987110 |
| 126 | MP0001243_abnormal_dermal_layer | 0.75433010 |
| 127 | MP0000778_abnormal_nervous_system | 0.75286112 |
| 128 | MP0002796_impaired_skin_barrier | 0.75159852 |
| 129 | MP0001849_ear_inflammation | 0.74804085 |
| 130 | MP0002084_abnormal_developmental_patter | 0.73988470 |
| 131 | MP0004133_heterotaxia | 0.73405108 |
| 132 | MP0001970_abnormal_pain_threshold | 0.73204130 |
| 133 | MP0005334_abnormal_fat_pad | 0.73109363 |
| 134 | MP0002396_abnormal_hematopoietic_system | 0.72729117 |
| 135 | MP0005621_abnormal_cell_physiology | 0.72669235 |
| 136 | MP0004858_abnormal_nervous_system | 0.72488121 |
| 137 | MP0000467_abnormal_esophagus_morphology | 0.72164163 |
| 138 | MP0001963_abnormal_hearing_physiology | 0.71708720 |
| 139 | MP0005409_darkened_coat_color | 0.71581164 |
| 140 | MP0010771_integument_phenotype | 0.70712408 |
| 141 | MP0000609_abnormal_liver_physiology | 0.70432179 |
| 142 | MP0005165_increased_susceptibility_to | 0.70430334 |
| 143 | MP0008260_abnormal_autophagy | 0.70373538 |
| 144 | MP0000759_abnormal_skeletal_muscle | 0.69471496 |
| 145 | MP0003959_abnormal_lean_body | 0.68757277 |
| 146 | MP0000358_abnormal_cell_content/ | 0.67987224 |
| 147 | MP0004742_abnormal_vestibular_system | 0.66586034 |
| 148 | MP0010386_abnormal_urinary_bladder | 0.66014772 |
| 149 | MP0005197_abnormal_uvea_morphology | 0.65404663 |
| 150 | MP0003634_abnormal_glial_cell | 0.63527803 |
| 151 | MP0004811_abnormal_neuron_physiology | 0.63471292 |
| 152 | MP0005084_abnormal_gallbladder_morpholo | 0.62846153 |
| 153 | MP0002184_abnormal_innervation | 0.60713685 |
| 154 | MP0000678_abnormal_parathyroid_gland | 0.59751960 |
| 155 | MP0000955_abnormal_spinal_cord | 0.58692534 |
| 156 | MP0003879_abnormal_hair_cell | 0.58146266 |
| 157 | MP0008569_lethality_at_weaning | 0.58024401 |
| 158 | MP0005386_behavior/neurological_phenoty | 0.57564347 |
| 159 | MP0004924_abnormal_behavior | 0.57564347 |
| 160 | MP0002332_abnormal_exercise_endurance | 0.56033354 |
| 161 | MP0002066_abnormal_motor_capabilities/c | 0.55488158 |
| 162 | MP0005394_taste/olfaction_phenotype | 0.53783285 |
| 163 | MP0005499_abnormal_olfactory_system | 0.53783285 |
| 164 | MP0002928_abnormal_bile_duct | 0.51233434 |
| 165 | MP0005595_abnormal_vascular_smooth | 0.49668774 |
| 166 | MP0001188_hyperpigmentation | 0.49172424 |
| 167 | MP0005187_abnormal_penis_morphology | 0.48241361 |
| 168 | MP0004043_abnormal_pH_regulation | 0.47258690 |
| 169 | MP0001440_abnormal_grooming_behavior | 0.47111968 |
| 170 | MP0004142_abnormal_muscle_tone | 0.46527254 |
| 171 | MP0002152_abnormal_brain_morphology | 0.45030225 |
| 172 | MP0002876_abnormal_thyroid_physiology | 0.44941071 |
| 173 | MP0002557_abnormal_social/conspecific_i | 0.44926023 |
| 174 | MP0000026_abnormal_inner_ear | 0.44769652 |
| 175 | MP0003633_abnormal_nervous_system | 0.44344936 |
| 176 | MP0000631_abnormal_neuroendocrine_gland | 0.43617652 |
| 177 | MP0008004_abnormal_stomach_pH | 0.41058192 |
| 178 | MP0003690_abnormal_glial_cell | 0.41023948 |
| 179 | MP0005646_abnormal_pituitary_gland | 0.40645825 |
| 180 | MP0010678_abnormal_skin_adnexa | 0.40532633 |
| 181 | MP0001177_atelectasis | 0.40474526 |
| 182 | MP0002127_abnormal_cardiovascular_syste | 0.39067806 |
| 183 | MP0003631_nervous_system_phenotype | 0.36956572 |
| 184 | MP0006276_abnormal_autonomic_nervous | 0.36569507 |
| 185 | MP0003075_altered_response_to | 0.36563714 |
| 186 | MP0002751_abnormal_autonomic_nervous | 0.35385503 |
| 187 | MP0004215_abnormal_myocardial_fiber | 0.34843318 |
| 188 | MP0000920_abnormal_myelination | 0.34724831 |
| 189 | MP0003632_abnormal_nervous_system | 0.33646689 |
| 190 | MP0002102_abnormal_ear_morphology | 0.33398396 |
| 191 | MP0000681_abnormal_thyroid_gland | 0.30556604 |
| 192 | MP0003303_peritoneal_inflammation | 0.30413909 |
| 193 | MP0000569_abnormal_digit_pigmentation | 0.30343797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dyschromatopsia (HP:0007641) | 9.18661135 |
| 2 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 9.18488051 |
| 3 | Abnormal rod and cone electroretinograms (HP:0008323) | 8.68349331 |
| 4 | Central scotoma (HP:0000603) | 7.97871798 |
| 5 | Pigmentary retinal degeneration (HP:0001146) | 7.95286740 |
| 6 | Abnormality of macular pigmentation (HP:0008002) | 7.75225295 |
| 7 | Attenuation of retinal blood vessels (HP:0007843) | 7.12562798 |
| 8 | Chorioretinal atrophy (HP:0000533) | 7.05981100 |
| 9 | Scotoma (HP:0000575) | 7.03371464 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.79262864 |
| 11 | Pendular nystagmus (HP:0012043) | 6.59439729 |
| 12 | Decreased central vision (HP:0007663) | 6.17951808 |
| 13 | Abolished electroretinogram (ERG) (HP:0000550) | 5.93421273 |
| 14 | Photophobia (HP:0000613) | 5.39526320 |
| 15 | Posterior subcapsular cataract (HP:0007787) | 5.28241711 |
| 16 | Type II diabetes mellitus (HP:0005978) | 5.21694273 |
| 17 | Choroideremia (HP:0001139) | 5.09024993 |
| 18 | Macular degeneration (HP:0000608) | 4.63375379 |
| 19 | Cone-rod dystrophy (HP:0000548) | 4.57639280 |
| 20 | Alkalosis (HP:0001948) | 4.54091026 |
| 21 | Severe visual impairment (HP:0001141) | 4.49711448 |
| 22 | Vitreoretinal degeneration (HP:0000655) | 4.42092550 |
| 23 | Keratoconus (HP:0000563) | 4.25419392 |
| 24 | Increased corneal curvature (HP:0100692) | 4.25419392 |
| 25 | Cerebellar dysplasia (HP:0007033) | 4.08775503 |
| 26 | Retinitis pigmentosa (HP:0000510) | 3.84591545 |
| 27 | Hypobetalipoproteinemia (HP:0003563) | 3.83968512 |
| 28 | Congenital sensorineural hearing impairment (HP:0008527) | 3.72870076 |
| 29 | Constricted visual fields (HP:0001133) | 3.72433117 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.71443946 |
| 31 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.49149030 |
| 32 | Hyperammonemia (HP:0001987) | 3.47308998 |
| 33 | Osteolytic defects of the hand bones (HP:0009699) | 3.40164310 |
| 34 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.40164310 |
| 35 | Elbow flexion contracture (HP:0002987) | 3.38346093 |
| 36 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.36976850 |
| 37 | Abnormality of alanine metabolism (HP:0010916) | 3.36976850 |
| 38 | Hyperalaninemia (HP:0003348) | 3.36976850 |
| 39 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.33887650 |
| 40 | Subcapsular cataract (HP:0000523) | 3.32685053 |
| 41 | Sparse lateral eyebrow (HP:0005338) | 3.16791085 |
| 42 | Submucous cleft hard palate (HP:0000176) | 3.12410566 |
| 43 | Cerebral edema (HP:0002181) | 3.09495235 |
| 44 | Ulnar bowing (HP:0003031) | 3.04856478 |
| 45 | Asymmetry of the thorax (HP:0001555) | 3.03018958 |
| 46 | Vertebral compression fractures (HP:0002953) | 3.02842523 |
| 47 | Malnutrition (HP:0004395) | 2.99046832 |
| 48 | Retinal atrophy (HP:0001105) | 2.93199547 |
| 49 | Short nail (HP:0001799) | 2.90335390 |
| 50 | Short chin (HP:0000331) | 2.85500237 |
| 51 | Abnormality of glycolysis (HP:0004366) | 2.84908415 |
| 52 | Progressive visual loss (HP:0000529) | 2.83533046 |
| 53 | Cutaneous melanoma (HP:0012056) | 2.74806951 |
| 54 | Calcaneovalgus deformity (HP:0001848) | 2.73133779 |
| 55 | Abnormality of the calcaneus (HP:0008364) | 2.70360084 |
| 56 | Increased serum pyruvate (HP:0003542) | 2.69289573 |
| 57 | Ragged-red muscle fibers (HP:0003200) | 2.68766061 |
| 58 | Impaired pain sensation (HP:0007328) | 2.66100391 |
| 59 | Abnormality of pain sensation (HP:0010832) | 2.66100391 |
| 60 | Microvesicular hepatic steatosis (HP:0001414) | 2.57807231 |
| 61 | Dysmetric saccades (HP:0000641) | 2.45908893 |
| 62 | Premature rupture of membranes (HP:0001788) | 2.45733131 |
| 63 | Achilles tendon contracture (HP:0001771) | 2.43443076 |
| 64 | Stroke (HP:0001297) | 2.43016816 |
| 65 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.42227198 |
| 66 | Hypolipoproteinemia (HP:0010981) | 2.41016916 |
| 67 | Hypercholesterolemia (HP:0003124) | 2.35713613 |
| 68 | Optic disc pallor (HP:0000543) | 2.35695328 |
| 69 | Chromsome breakage (HP:0040012) | 2.35059802 |
| 70 | Gait imbalance (HP:0002141) | 2.33410138 |
| 71 | Squamous cell carcinoma (HP:0002860) | 2.33290325 |
| 72 | Broad face (HP:0000283) | 2.32420832 |
| 73 | Wide nasal bridge (HP:0000431) | 2.31751621 |
| 74 | Entropion (HP:0000621) | 2.28908212 |
| 75 | Congenital primary aphakia (HP:0007707) | 2.26601738 |
| 76 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.25603223 |
| 77 | Deformed tarsal bones (HP:0008119) | 2.25207121 |
| 78 | Abnormality of the Achilles tendon (HP:0005109) | 2.24696573 |
| 79 | Knee flexion contracture (HP:0006380) | 2.24028051 |
| 80 | Neurodegeneration (HP:0002180) | 2.23559575 |
| 81 | Progressive muscle weakness (HP:0003323) | 2.23507049 |
| 82 | Wormian bones (HP:0002645) | 2.22317229 |
| 83 | Abnormality of serum amino acid levels (HP:0003112) | 2.21240289 |
| 84 | Deviation of the thumb (HP:0009603) | 2.19245639 |
| 85 | Abnormality of oral frenula (HP:0000190) | 2.14952844 |
| 86 | Proximal placement of thumb (HP:0009623) | 2.13761183 |
| 87 | Partial agenesis of the corpus callosum (HP:0001338) | 2.12491674 |
| 88 | Febrile seizures (HP:0002373) | 2.12374914 |
| 89 | Nephrogenic diabetes insipidus (HP:0009806) | 2.11883860 |
| 90 | Renal duplication (HP:0000075) | 2.10784514 |
| 91 | Ankyloglossia (HP:0010296) | 2.09425483 |
| 92 | Termporal pattern (HP:0011008) | 2.06056716 |
| 93 | Insidious onset (HP:0003587) | 2.06056716 |
| 94 | Dysdiadochokinesis (HP:0002075) | 2.04738191 |
| 95 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.02732673 |
| 96 | Aplasia of the phalanges of the hand (HP:0009802) | 2.02732673 |
| 97 | Aplasia involving bones of the extremities (HP:0009825) | 2.02732673 |
| 98 | Relative macrocephaly (HP:0004482) | 2.02618188 |
| 99 | Hypoplastic nipples (HP:0002557) | 2.00332843 |
| 100 | Congenital stationary night blindness (HP:0007642) | 12.9301129 |
| 101 | Bony spicule pigmentary retinopathy (HP:0007737) | 10.4841239 |
| 102 | Astrocytoma (HP:0009592) | 1.96791942 |
| 103 | Abnormality of the astrocytes (HP:0100707) | 1.96791942 |
| 104 | Flat acetabular roof (HP:0003180) | 1.95040689 |
| 105 | Hyperacusis (HP:0010780) | 1.94843949 |
| 106 | Natal tooth (HP:0000695) | 1.93286057 |
| 107 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.92236230 |
| 108 | Fibular hypoplasia (HP:0003038) | 1.90203205 |
| 109 | Epileptic encephalopathy (HP:0200134) | 1.87757685 |
| 110 | Medial flaring of the eyebrow (HP:0010747) | 1.87745886 |
| 111 | Selective tooth agenesis (HP:0001592) | 1.86594818 |
| 112 | Mitral stenosis (HP:0001718) | 1.86477795 |
| 113 | Polar cataract (HP:0010696) | 1.86083687 |
| 114 | Deep philtrum (HP:0002002) | 1.85079558 |
| 115 | Adducted thumb (HP:0001181) | 1.84582062 |
| 116 | Subacute progressive viral hepatitis (HP:0006572) | 1.82866387 |
| 117 | Hyperparathyroidism (HP:0000843) | 1.82707018 |
| 118 | Clumsiness (HP:0002312) | 1.77876164 |
| 119 | Truncal ataxia (HP:0002078) | 1.77060397 |
| 120 | Focal segmental glomerulosclerosis (HP:0000097) | 1.76919800 |
| 121 | Pancreatic fibrosis (HP:0100732) | 1.76875972 |
| 122 | Abnormality of the periventricular white matter (HP:0002518) | 1.76642952 |
| 123 | Bifid uvula (HP:0000193) | 1.74531697 |
| 124 | Overlapping toe (HP:0001845) | 1.74057008 |
| 125 | Megaloblastic anemia (HP:0001889) | 1.72133539 |
| 126 | Glomerulosclerosis (HP:0000096) | 1.70924193 |
| 127 | Abnormality of the nasal septum (HP:0000419) | 1.70342247 |
| 128 | Poor coordination (HP:0002370) | 1.68732491 |
| 129 | Genital tract atresia (HP:0001827) | 1.67620520 |
| 130 | Abnormality of the tricuspid valve (HP:0001702) | 1.67334557 |
| 131 | Myoglobinuria (HP:0002913) | 1.67010864 |
| 132 | Protruding tongue (HP:0010808) | 1.65028855 |
| 133 | Horizontal nystagmus (HP:0000666) | 1.64382525 |
| 134 | Neoplasm of head and neck (HP:0012288) | 1.63832859 |
| 135 | Esophageal neoplasm (HP:0100751) | 1.63832859 |
| 136 | Prominent nose (HP:0000448) | 1.63829506 |
| 137 | Sandal gap (HP:0001852) | 1.63143051 |
| 138 | Persistence of primary teeth (HP:0006335) | 1.62717857 |
| 139 | Ureteral duplication (HP:0000073) | 1.62617962 |
| 140 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.62514573 |
| 141 | Vaginal atresia (HP:0000148) | 1.61924266 |
| 142 | Birth length less than 3rd percentile (HP:0003561) | 1.61337816 |
| 143 | Increased connective tissue (HP:0009025) | 1.58737805 |
| 144 | Delayed cranial suture closure (HP:0000270) | 1.57702705 |
| 145 | Overriding aorta (HP:0002623) | 1.57405307 |
| 146 | Micronodular cirrhosis (HP:0001413) | 1.57005777 |
| 147 | Abnormality of the ischium (HP:0003174) | 1.56769238 |
| 148 | Glioma (HP:0009733) | 1.56536756 |
| 149 | True hermaphroditism (HP:0010459) | 1.56270705 |
| 150 | Focal motor seizures (HP:0011153) | 1.55488907 |
| 151 | Autoamputation (HP:0001218) | 1.55197935 |
| 152 | Focal seizures (HP:0007359) | 1.54738867 |
| 153 | Tibial bowing (HP:0002982) | 1.54546789 |
| 154 | Oligodactyly (hands) (HP:0001180) | 1.47010978 |
| 155 | Cystic liver disease (HP:0006706) | 1.45681814 |
| 156 | Supernumerary nipples (HP:0002558) | 1.44542100 |
| 157 | Broad-based gait (HP:0002136) | 1.42492592 |
| 158 | Optic atrophy (HP:0000648) | 1.39954582 |
| 159 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.35491222 |
| 160 | Prolonged QT interval (HP:0001657) | 1.32122260 |
| 161 | Severe Myopia (HP:0011003) | 1.29363557 |
| 162 | Hyperventilation (HP:0002883) | 1.26308691 |
| 163 | Specific learning disability (HP:0001328) | 1.26207518 |
| 164 | Neoplasm of the heart (HP:0100544) | 1.24332875 |
| 165 | Turricephaly (HP:0000262) | 1.22583770 |
| 166 | Supranuclear gaze palsy (HP:0000605) | 1.22522397 |
| 167 | Left ventricular hypertrophy (HP:0001712) | 1.21647064 |
| 168 | Progressive cerebellar ataxia (HP:0002073) | 1.18162859 |
| 169 | Interstitial pulmonary disease (HP:0006530) | 1.17210929 |
| 170 | Retinal detachment (HP:0000541) | 1.15129144 |
| 171 | Dysmetria (HP:0001310) | 1.14325342 |
| 172 | Syncope (HP:0001279) | 1.14164558 |
| 173 | Abnormal EKG (HP:0003115) | 1.13167070 |
| 174 | Dialeptic seizures (HP:0011146) | 1.12996460 |
| 175 | Visual hallucinations (HP:0002367) | 1.10674450 |
| 176 | Postural instability (HP:0002172) | 1.09470311 |
| 177 | Pancreatic cysts (HP:0001737) | 1.09124053 |
| 178 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.09121372 |
| 179 | Absence seizures (HP:0002121) | 1.07831239 |
| 180 | Excessive salivation (HP:0003781) | 1.06325492 |
| 181 | Drooling (HP:0002307) | 1.06325492 |
| 182 | Fair hair (HP:0002286) | 1.05838571 |
| 183 | Macroorchidism (HP:0000053) | 1.03925585 |
| 184 | Thoracic kyphosis (HP:0002942) | 1.02602987 |
| 185 | Atonic seizures (HP:0010819) | 1.02496730 |
| 186 | Scanning speech (HP:0002168) | 1.02330855 |
| 187 | Short foot (HP:0001773) | 1.01021758 |
| 188 | Insomnia (HP:0100785) | 1.00770710 |
| 189 | Astigmatism (HP:0000483) | 1.00318010 |
| 190 | Elfin facies (HP:0004428) | 0.99177270 |
| 191 | Flat cornea (HP:0007720) | 0.95780515 |
| 192 | Generalized tonic-clonic seizures (HP:0002069) | 0.95686180 |
| 193 | Distal lower limb amyotrophy (HP:0008944) | 0.94133951 |
| 194 | Absent speech (HP:0001344) | 0.93909949 |
| 195 | Atrial fibrillation (HP:0005110) | 0.92882717 |
| 196 | Exotropia (HP:0000577) | 0.92313380 |
| 197 | Cutaneous finger syndactyly (HP:0010554) | 0.91518318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK2 | 7.65157900 |
| 2 | NTRK3 | 6.99094466 |
| 3 | MST1R | 6.37442037 |
| 4 | GRK1 | 5.11455482 |
| 5 | EPHA4 | 3.19472124 |
| 6 | MET | 2.83294938 |
| 7 | NEK1 | 2.56535695 |
| 8 | BRSK2 | 2.42150413 |
| 9 | TTN | 2.41704000 |
| 10 | EEF2K | 2.14403276 |
| 11 | STK38 | 2.12135411 |
| 12 | NLK | 2.12101620 |
| 13 | EIF2AK1 | 2.02619515 |
| 14 | TNIK | 10.3184529 |
| 15 | NME2 | 1.91419301 |
| 16 | MAP3K14 | 1.84979414 |
| 17 | PRPF4B | 1.77197106 |
| 18 | MAP3K9 | 1.76474865 |
| 19 | PBK | 1.72486308 |
| 20 | MAPKAPK5 | 1.65894601 |
| 21 | MKNK1 | 1.63526690 |
| 22 | CAMKK2 | 1.57260343 |
| 23 | ACVR1B | 1.55278738 |
| 24 | NEK6 | 1.53002531 |
| 25 | RPS6KB2 | 1.49667154 |
| 26 | BUB1 | 1.48635920 |
| 27 | TLK1 | 1.48447175 |
| 28 | WNK4 | 1.46139502 |
| 29 | CDC7 | 1.45267418 |
| 30 | MAP2K7 | 1.39581461 |
| 31 | IRAK3 | 1.30872624 |
| 32 | ERBB4 | 1.29763035 |
| 33 | BRSK1 | 1.28871747 |
| 34 | FES | 1.27659744 |
| 35 | LATS2 | 1.22597531 |
| 36 | DAPK2 | 1.19224418 |
| 37 | PINK1 | 1.16149491 |
| 38 | BMPR2 | 1.14985129 |
| 39 | AURKB | 1.12093625 |
| 40 | MAPK13 | 1.10684909 |
| 41 | TAOK1 | 1.10676767 |
| 42 | WEE1 | 1.09230687 |
| 43 | MAP3K4 | 1.08312426 |
| 44 | CAMK1 | 1.02290288 |
| 45 | SIK2 | 1.02117870 |
| 46 | TSSK6 | 1.01343886 |
| 47 | CCNB1 | 0.99140286 |
| 48 | BRD4 | 0.98281205 |
| 49 | EIF2AK3 | 0.95990380 |
| 50 | MARK1 | 0.94571041 |
| 51 | MARK2 | 0.93454527 |
| 52 | CDK6 | 0.92840178 |
| 53 | RIPK1 | 0.92064412 |
| 54 | NEK2 | 0.91155002 |
| 55 | MAPK11 | 0.84998649 |
| 56 | PRKG2 | 0.84618252 |
| 57 | MAP3K7 | 0.84374897 |
| 58 | MAP2K2 | 0.84219883 |
| 59 | STK16 | 0.84175937 |
| 60 | CAMK4 | 0.83995514 |
| 61 | WNK1 | 0.81702347 |
| 62 | PIM2 | 0.80141896 |
| 63 | HIPK2 | 0.78996583 |
| 64 | ERBB2 | 0.78684072 |
| 65 | CAMK1G | 0.77804002 |
| 66 | CDK12 | 0.77520283 |
| 67 | CAMK2D | 0.77355190 |
| 68 | MAPK12 | 0.75475376 |
| 69 | SRPK1 | 0.74926332 |
| 70 | CAMK2A | 0.72142737 |
| 71 | MTOR | 0.71254036 |
| 72 | ADRBK1 | 0.70827096 |
| 73 | PAK4 | 0.70704760 |
| 74 | CSNK1D | 0.70116705 |
| 75 | PAK6 | 0.68792338 |
| 76 | CHEK2 | 0.67425077 |
| 77 | MAP2K1 | 0.67137260 |
| 78 | TESK1 | 0.66891712 |
| 79 | CDC42BPA | 0.66547354 |
| 80 | CASK | 0.66328921 |
| 81 | PLK1 | 0.65700804 |
| 82 | PDPK1 | 0.65439232 |
| 83 | INSRR | 0.65178771 |
| 84 | RPS6KA5 | 0.63078498 |
| 85 | ATR | 0.61474635 |
| 86 | TRIB3 | 0.61100286 |
| 87 | MAPK7 | 0.60794649 |
| 88 | TAOK3 | 0.60268007 |
| 89 | AURKA | 0.59741978 |
| 90 | CDK8 | 0.59241976 |
| 91 | TAOK2 | 0.59050969 |
| 92 | AKT3 | 0.58054652 |
| 93 | SGK1 | 0.58025431 |
| 94 | CAMK1D | 0.57861964 |
| 95 | EPHA2 | 0.57744700 |
| 96 | CDK5 | 0.56117129 |
| 97 | IRAK2 | 0.55054907 |
| 98 | CDK7 | 0.54626882 |
| 99 | SGK223 | 0.54425807 |
| 100 | SGK494 | 0.54425807 |
| 101 | TTK | 0.52830497 |
| 102 | SIK1 | 0.51181245 |
| 103 | DAPK1 | 0.51162714 |
| 104 | PRKCH | 0.50984426 |
| 105 | CDK4 | 0.48884159 |
| 106 | PRKCG | 0.48625575 |
| 107 | SGK2 | 0.47822559 |
| 108 | MINK1 | 0.47788544 |
| 109 | PRKCB | 0.47740500 |
| 110 | MELK | 0.45466674 |
| 111 | PIM1 | 0.44993999 |
| 112 | SCYL2 | 0.43693676 |
| 113 | PAK2 | 0.43471540 |
| 114 | NEK9 | 0.43090698 |
| 115 | MAP3K8 | 0.42651605 |
| 116 | FER | 0.42513446 |
| 117 | PRKD3 | 0.42457513 |
| 118 | ERN1 | 0.41863822 |
| 119 | ABL2 | 0.41645858 |
| 120 | EIF2AK2 | 0.41350776 |
| 121 | SMG1 | 0.41062498 |
| 122 | MAP3K12 | 0.41052612 |
| 123 | PRKCQ | 0.40081840 |
| 124 | PHKG1 | 0.39422099 |
| 125 | PHKG2 | 0.39422099 |
| 126 | GRK5 | 0.39290153 |
| 127 | CHEK1 | 0.38987051 |
| 128 | RPS6KA3 | 0.38967491 |
| 129 | STK39 | 0.38872708 |
| 130 | MAP3K13 | 0.38413110 |
| 131 | DYRK1A | 0.38176796 |
| 132 | PLK2 | 0.36747042 |
| 133 | MAPKAPK3 | 0.36243757 |
| 134 | MAPK4 | 0.36041576 |
| 135 | NTRK2 | 0.35952484 |
| 136 | CAMK2G | 0.35720645 |
| 137 | CAMKK1 | 0.35618976 |
| 138 | YES1 | 0.34913438 |
| 139 | BMX | 0.34786246 |
| 140 | CDK1 | 0.34642263 |
| 141 | NME1 | 0.34575612 |
| 142 | MAP2K4 | 0.34220054 |
| 143 | JAK1 | 0.33419388 |
| 144 | PKN1 | 0.33206500 |
| 145 | BRAF | 0.32949537 |
| 146 | PRKACG | 0.32865116 |
| 147 | CAMK2B | 0.32630700 |
| 148 | MAP3K1 | 0.32591094 |
| 149 | LATS1 | 0.32267994 |
| 150 | ERBB3 | 0.32048760 |
| 151 | PNCK | 0.31967620 |
| 152 | SGK3 | 0.31960343 |
| 153 | PRKAA1 | 0.31298974 |
| 154 | AKT2 | 0.31041127 |
| 155 | CDK2 | 0.30834211 |
| 156 | RAF1 | 0.30710029 |
| 157 | PTK2 | 0.30676550 |
| 158 | GSK3B | 0.29710594 |
| 159 | ZAK | 0.29056970 |
| 160 | FGFR1 | 0.27875822 |
| 161 | PRKCZ | 0.27767870 |
| 162 | RPS6KB1 | 0.27303655 |
| 163 | TRPM7 | 0.27210831 |
| 164 | PRKD2 | 0.26923745 |
| 165 | KSR2 | 0.26132855 |
| 166 | ICK | 0.26111300 |
| 167 | PRKG1 | 0.25795859 |
| 168 | PRKCA | 0.23282440 |
| 169 | MYLK | 0.23132268 |
| 170 | PAK3 | 0.23089321 |
| 171 | PRKD1 | 0.22304736 |
| 172 | STK11 | 0.21911300 |
| 173 | PRKAA2 | 0.21366384 |
| 174 | PRKDC | 0.21168778 |
| 175 | FYN | 0.20791920 |
| 176 | CSNK1E | 0.20694436 |
| 177 | OXSR1 | 0.20585737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.83955646 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.07076110 |
| 3 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 3.06003355 |
| 4 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.72932850 |
| 5 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.63874669 |
| 6 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.38755390 |
| 7 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.25254012 |
| 8 | Carbon metabolism_Homo sapiens_hsa01200 | 2.10049745 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.00489835 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 13.7968817 |
| 11 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.95611394 |
| 12 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.92602213 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.87838704 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.84345467 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.83848570 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 1.79429603 |
| 17 | Galactose metabolism_Homo sapiens_hsa00052 | 1.74003588 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.73614136 |
| 19 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.68842925 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.65218330 |
| 21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.64449662 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.63670545 |
| 23 | GABAergic synapse_Homo sapiens_hsa04727 | 1.63368984 |
| 24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.55402405 |
| 25 | Cell cycle_Homo sapiens_hsa04110 | 1.54022323 |
| 26 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.49977218 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.47617459 |
| 28 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.47253325 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.47214692 |
| 30 | Circadian entrainment_Homo sapiens_hsa04713 | 1.43243629 |
| 31 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.39769505 |
| 32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.39658214 |
| 33 | Morphine addiction_Homo sapiens_hsa05032 | 1.35311814 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.27979511 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.17753093 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.16387820 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.16229323 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16194822 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15386196 |
| 40 | Long-term potentiation_Homo sapiens_hsa04720 | 1.14412521 |
| 41 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.14302810 |
| 42 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.09857091 |
| 43 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.08518985 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 1.07171170 |
| 45 | RNA transport_Homo sapiens_hsa03013 | 1.06727390 |
| 46 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.03324213 |
| 47 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.02078706 |
| 48 | Insulin secretion_Homo sapiens_hsa04911 | 1.01851337 |
| 49 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.01476829 |
| 50 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.00325634 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.97934976 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.95488357 |
| 53 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.95119660 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92122950 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 0.91598473 |
| 56 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.90836159 |
| 57 | Renin secretion_Homo sapiens_hsa04924 | 0.90334387 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89272350 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88989883 |
| 60 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.88735855 |
| 61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.87115754 |
| 62 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86465127 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.85500526 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.84027762 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83972097 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82559537 |
| 67 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.82549511 |
| 68 | Salivary secretion_Homo sapiens_hsa04970 | 0.82048239 |
| 69 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.79930576 |
| 70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.78166071 |
| 71 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77867739 |
| 72 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.76094489 |
| 73 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.75873410 |
| 74 | Taste transduction_Homo sapiens_hsa04742 | 0.74890661 |
| 75 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.74809587 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.74556448 |
| 77 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74218467 |
| 78 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74100567 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.74065063 |
| 80 | Base excision repair_Homo sapiens_hsa03410 | 0.73554164 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73069019 |
| 82 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.73028161 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.72721448 |
| 84 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72417224 |
| 85 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.72352831 |
| 86 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.71805308 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71344361 |
| 88 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66396513 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64496905 |
| 90 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64470806 |
| 91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64397287 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63828422 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61245483 |
| 94 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.61186592 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59584250 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59334411 |
| 97 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.57276152 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56616531 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.56293848 |
| 100 | Cocaine addiction_Homo sapiens_hsa05030 | 0.56267282 |
| 101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55937821 |
| 102 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.55860569 |
| 103 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55649066 |
| 104 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55267755 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54407009 |
| 106 | Axon guidance_Homo sapiens_hsa04360 | 0.53621113 |
| 107 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52782881 |
| 108 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.52133085 |
| 109 | Ribosome_Homo sapiens_hsa03010 | 0.51639423 |
| 110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50521669 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.50280423 |
| 112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49117848 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48924749 |
| 114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47550795 |
| 115 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47235603 |
| 116 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.44585875 |
| 117 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44427541 |
| 118 | Homologous recombination_Homo sapiens_hsa03440 | 0.44215163 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43029959 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42419626 |
| 121 | Long-term depression_Homo sapiens_hsa04730 | 0.41954630 |
| 122 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41224716 |
| 123 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41161688 |
| 124 | Adherens junction_Homo sapiens_hsa04520 | 0.39657603 |
| 125 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.38298589 |
| 126 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38211856 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38103983 |
| 128 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38084760 |
| 129 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37825982 |
| 130 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37750319 |
| 131 | Bile secretion_Homo sapiens_hsa04976 | 0.37100267 |
| 132 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35336510 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35161184 |
| 134 | Melanogenesis_Homo sapiens_hsa04916 | 0.34674835 |
| 135 | Mineral absorption_Homo sapiens_hsa04978 | 0.34588436 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34241104 |
| 137 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.33995111 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33387848 |
| 139 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33324227 |
| 140 | Spliceosome_Homo sapiens_hsa03040 | 0.33229984 |
| 141 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.33115867 |
| 142 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32780652 |
| 143 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32441527 |
| 144 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32058049 |
| 145 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31295935 |
| 146 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.30564110 |
| 147 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.29284477 |
| 148 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.29235808 |
| 149 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29182593 |
| 150 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.29108152 |
| 151 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28985335 |
| 152 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28745144 |
| 153 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.28211784 |
| 154 | Bladder cancer_Homo sapiens_hsa05219 | 0.26127536 |
| 155 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25685196 |
| 156 | Alcoholism_Homo sapiens_hsa05034 | 0.25281569 |
| 157 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25268911 |
| 158 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25161031 |
| 159 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22793714 |
| 160 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.22421195 |
| 161 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22100591 |
| 162 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21387207 |
| 163 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.21035463 |
| 164 | Thyroid cancer_Homo sapiens_hsa05216 | 0.21019778 |
| 165 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.19485373 |
| 166 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.18373082 |
| 167 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.17065699 |
| 168 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.16464538 |
| 169 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.16036455 |
| 170 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.14307828 |
| 171 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.13580741 |
| 172 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.13464239 |
| 173 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12091155 |
| 174 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.11737899 |
| 175 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.11033413 |
| 176 | Purine metabolism_Homo sapiens_hsa00230 | 0.11011317 |
| 177 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.08439017 |

